JIN-001

N/A

Report date: 2023/03/02 11:30:21
NME

Base Information

Drug NameJIN-001
Drug Alias NameJIN-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsSolid tumoursParkinson DiseaseGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJ INTS BIO Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJ INTS BIO Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursParkinson DiseaseGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A